Status
ACTIVE
Global HQ
Montreal, Canada
Countries of investment
- Canada
Investment stages
- Seed
- Series A
Industries
- Life Sciences
- Health Tech
- Biotechnology
- MedTech
About
AmorChem is a leading early stage venture fund creating innovative biotech companies from academic research, with a focus on groundbreaking therapies.
AmorChem is a leading early stage venture fund creating innovative biotech companies from academic research, with a focus on groundbreaking therapies.
Investment Thesis
AmorChem is a leading early stage venture capital fund dedicated to creating a new generation of biotechnology companies, from university research to innovative biotech startups. They leverage academic entrepreneurship to generate sustainable health and wealth and focus on translational research to accelerate therapeutic drug discovery and development across a broad spectrum of disease areas.
Manager's Experience
Focused on technology investments across North America and Europe, the manager has actively participated in 50+ deals. Specializes in late-stage companies with a preference for scalable business models. Known for driving successful exits, achieving a robust portfolio return through strategic partnerships. Backed by a top-tier network, the approach emphasizes a hands-on operational support model to enhance growth trajectories.
Team
Inès Holzbaur
John Clement
Maxime Ranger